Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.97

+0.4%

1:24 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nancy who wrote (1048)	11/14/1998 12:36:00 PM
From: Anthony Wong	Read Replies (1) of 1722

Nancy, the retail price for Enbrel and Remicade: Arthritis drug Enbrel shows long term safety: Study biz.yahoo.com Researchers said patients might find the drug [Remicade], which is given intravenously once every eight weeks, more convenient to use than Enbrel which has to be self-injected twice a week. Remicade may also be cheaper than Enbrel which will cost about $220 a week while analysts expect Remicade will cost between $96 and $156 a week.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next